Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
It’s not often that a company with the scale and…
Sell
23
DIVP Quote, Financials, Valuation and Earnings
Last price:
$25.40
Seasonality move
:
--
Day range:
$25.14 - $25.41
52-week range:
$24.76 - $27.15
Dividend yield:
4.58%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
--
Volume:
1.2K
Avg. volume:
--
1-year change:
--
Market cap:
--
Revenue:
--
EPS (TTM):
--
Earnings Data
Next earnings date for DIVP
--
Most recent earnings per share
--
Missed by --
(Dec 23/2024)
Consensus Estimate
--
(Dec 23/2024)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
DIVP Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|
Cullen Enhanced Equity Income ETF Earnings Questions
-
How Much did Cullen Enhanced Equity Income ETF Generate in Revenue Last Quarter?
Cullen Enhanced Equity Income ETF reported -- worth of top line sales in its most recent quarter.
-
Did Cullen Enhanced Equity Income ETF Beat Earnings Last Quarter?
Cullen Enhanced Equity Income ETF announced earnings per share of -- which represents a miss of analyst forecast a -- per share.
-
Is Cullen Enhanced Equity Income ETF Profitable?
Cullen Enhanced Equity Income ETF reported -- that represents -- per share over the last quarter.
-
What is the Analyst Consensus for Cullen Enhanced Equity Income ETF EPS Next Year?
Cullen Enhanced Equity Income ETF's earnings are forecast to grow from -- per share to -- per share next year representing an increase of --.
-
When is Cullen Enhanced Equity Income ETF's Earnings Date?
Currently, Cullen Enhanced Equity Income ETF has not yet stated when its earnings date is, however, based on past estimates it's likely to take place on March 24, 2025.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will Tyson Foods Stock Bounce Back?
Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…
Will Iovance Biotherapeutics Stock Bounce Back?
Iovance Biotherapeutics (NASDAQ:IOVA) is a fledgling pharmaceutical company that specializes…
Stock Ideas
Buy
64
Is AAPL Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 42x
Buy
52
Is NVDA Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 113x
Buy
55
Is MSFT Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 37x
Alerts
Buy
61
QMCO alert for Dec 21
Quantum [QMCO] is up 26.28% over the past day.
Sell
46
NUKK alert for Dec 21
Nukkleus [NUKK] is down 22.94% over the past day.
Sell
1
IIPR alert for Dec 21
Innovative Industrial Properties [IIPR] is down 22.7% over the past day.
